Open AccessDrug eluting balloons for the treatment of coronary artery disease: What can we expect?
Author(s) -
Alexander Joost,
Volkhard Kurowski,
Peter W. Radke
Publication year - 2010
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v2.i9.257
Subject(s) - medicine , restenosis , drug , coronary artery disease , cardiology , interventional cardiology , balloon , drug eluting stent , stent , intensive care medicine , pharmacology
Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patients with diffuse in-stent restenosis (ISR). At present, however, a number of questions regarding long-term efficacy and safety remain, specifically in indications other than diffuse ISR. The results of the evaluation of different substances, balloon systems and clinical indications will determine the long-term success of DEBs.